Solitary Fibrous Tumor Treatment Market to Generate US$ 59.3 Million by 2031 | Growth & Key Business Strategies

According to the report, the global solitary fibrous tumor treatment market was valued at US$ 36.5 Mn in 2020 and is expected to reach US$ 59.3 Mn at a CAGR of 4.5% from 2021 to 2031. Solitary fibrous tumor (SFT) is a rare tumor of mesenchymal origin that accounts for less than 2% of all soft tissue masses. Initially identified in the pleura, SFT has been identified in multiple anatomic locations and can arise anywhere in the body. These tumors occur equally in both men and women, most frequently in the 6th and 7th decades of life.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 (𝐔𝐬𝐞 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐌𝐚𝐢𝐥 𝐈𝐝 𝐟𝐨𝐫 𝐐𝐮𝐢𝐜𝐤 𝐑𝐞𝐬𝐩𝐨𝐧𝐬𝐞) - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=37022

𝐈𝐦𝐩𝐫𝐨𝐯𝐞𝐝 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐏𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞𝐬 𝐭𝐨 𝐃𝐫𝐢𝐯𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭

In the past few decades, sustained advances through research & technology have led to more reliable methods for differentiating this distinct soft tissue tumor. Advances, specifically in immunohistochemistry and molecular diagnostics, have identified CD34 as the most consistent marker in solitary fibrous tumor. More recently, the discovery of the NAB2-STAT6 fusion gene has led to more precise diagnosis of solitary fibrous tumor. Hence, improvement and new development of diagnostic procedures are anticipated to drive the global solitary fibrous tumor treatment market.

𝐇𝐢𝐠𝐡 𝐂𝐨𝐬𝐭 𝐨𝐟 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐭𝐨 𝐇𝐚𝐦𝐩𝐞𝐫 𝐆𝐥𝐨𝐛𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭

Several studies have suggested that people with rare diseases face higher healthcare costs than those with common diseases. Solitary fibrous tumor is a very rare disease. Treatment involves surgery and therapies such as radiation therapy and chemotherapy. However, high cost of therapies and other immunotherapies is expected to deter patients from availing these treatments.

𝐒𝐮𝐫𝐠𝐞𝐫𝐲 𝐭𝐨 𝐛𝐞 𝐑𝐞𝐦𝐚𝐢𝐧 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐞𝐭𝐡𝐨𝐝

The global solitary fibrous tumor treatment market has been segmented based on treatment and end-user. In terms of treatment, the global solitary fibrous tumor market has been classified into surgery, radiation therapy, and adjuvant chemotherapy. The surgery segment is likely to account for major share of the global market by 2031, due to increase in demand for surgery, as surgical management has been the mainstay treatment for solitary fibrous tumor.

𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥𝐬 𝐭𝐨 𝐛𝐞 𝐊𝐞𝐲 𝐄𝐧𝐝-𝐮𝐬𝐞𝐫

In terms of end-user, the global solitary fibrous tumor treatment market has been divided into hospitals, ambulatory surgical centers, and others. The hospitals segment is projected to expand at a high CAGR during the forecast period due to rise in patient preference for all types of treatment facility under one roof.

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 | 𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐚𝐭 - https://www.transparencymarketresearch.com/checkout.php?rep_id=37022<ype=S

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐭𝐨 𝐃𝐨𝐦𝐢𝐧𝐚𝐭𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭

The global solitary fibrous tumor treatment market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global solitary fibrous tumor treatment market in 2020, followed by Europe. North America accounted for major share of the global solitary fibrous tumor treatment market in 2020 due to high awareness and increase in demand for disease risk assessment services for cancer treatment.

The solitary fibrous tumor treatment market in Asia Pacific is projected to expand at a high CAGR from 2021 to 2031. Rise in number of patients, high healthcare expenditure, and geographic expansion by major players, especially in China and India, are anticipated to drive the solitary fibrous tumor treatment market in the region.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐨𝐧 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

The report also presents profiles of leading players in the global solitary fibrous tumor treatment market. These include Pfizer, Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Bayer AG, and Novartis AG.

𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐨𝐥𝐢𝐭𝐚𝐫𝐲 𝐅𝐢𝐛𝐫𝐨𝐮𝐬 𝐓𝐮𝐦𝐨𝐫 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

𝐒𝐨𝐥𝐢𝐭𝐚𝐫𝐲 𝐅𝐢𝐛𝐫𝐨𝐮𝐬 𝐓𝐮𝐦𝐨𝐫 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐛𝐲 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭

Surgery
Radiation Therapy
Adjuvant Chemotherapy

𝐒𝐨𝐥𝐢𝐭𝐚𝐫𝐲 𝐅𝐢𝐛𝐫𝐨𝐮𝐬 𝐓𝐮𝐦𝐨𝐫 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐛𝐲 𝐄𝐧𝐝-𝐮𝐬𝐞𝐫

Hospitals
Ambulatory Surgical Clinics
Others

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 -

𝐅𝐞𝐭𝐚𝐥 𝐁𝐨𝐯𝐢𝐧𝐞 𝐒𝐞𝐫𝐮𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.prnewswire.com/news-releases/fetal-bovine-serum-market-to-exceed-us-1-6-bn-by-2031-rise-in-application-in-cell-culture-products-propelling-revenue-growth-finds-tmr-study-301539278.html

𝐁𝐫𝐞𝐚𝐬𝐭 𝐏𝐮𝐦𝐩𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.globenewswire.com/news-release/2022/03/15/2402991/0/en/Breast-Pumps-Market-to-Advance-at-CAGR-of-10-4-during-2019-2027-Recommendations-on-Meeting-Individual-Needs-of-Mothers-to-Improve-Effectiveness-TMR-Study.html

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.